Adenovirus-mediated transfer of an Na+/K+-ATPase beta1 subunit gene improves alveolar fluid clearance and survival in hyperoxic rats.
Pulmonary edema is cleared via active Na(+) transport by alveolar epithelial Na(+)/K(+)-ATPases and Na(+) channels. Rats exposed to acute hyperoxia have a high mortality rate, decreased Na(+)/K(+)-ATPase function, and decreased alveolar fluid clearance (AFC). We hypothesized that Na(+)/K(+)-ATPase subunit gene overexpression could improve AFC in rats exposed to hyperoxia. We delivered 4 x 10(9) PFU of recombinant adenoviruses containing rat alpha(1) and beta(1) Na(+)/K(+)-ATPase subunit cDNAs (adalpha(1) and adbeta(1), respectively) to rat lungs 7 days prior to exposure to 100% O(2) for 64 hr. As compared with controls and ad alpha(1), AFC in the adbeta(1) rats was increased by >300%. Permeability for large solutes was less in the ad beta(1) than in the other hyperoxia groups. Glutathione oxidation, but not superoxide dismutase activity, was increased only in the adbeta(1) group. Survival through 14 days of hyperoxia was 100% in the adbeta(1) group but was not different from hyperoxic controls in animals given adalpha(1). Our data show that overexpression of a beta(1) Na(+)/K(+)-ATPase subunit augments AFC and improves survival in this model of acute lung injury via antioxidant-independent mechanisms. Conceivably, restoration of AFC via gene transfer of Na(+)/K(+)-ATPase subunit genes may prove useful for the treatment of acute lung injury and pulmonary edema.
Factor
P
P
Pulmonary and Critical Care Medicine, Evanston Northwestern Healthcare, Evanston, IL 60201, USA. pfactor@northwestern.edu
Dumasius
V
V
Saldias
F
F
Brown
L A
LA
Sznajder
J I
JI
D000256:Adenoviridae / Q000235:genetics*; D000818:Animals; D000975:Antioxidants / Q000494:pharmacology; D015152:Blotting, Northern; D001992:Bronchoalveolar Lavage Fluid; D002460:Cell Line; D018076:DNA, Complementary / Q000235:genetics; D004234:Diuretics, Osmotic / Q000378:metabolism; D018014:Gene Transfer Techniques; D005978:Glutathione / Q000378:metabolism; D006801:Humans; D018496:Hyperoxia / Q000628:therapy*; D007150:Immunohistochemistry; D008168:Lung / Q000378:metabolism / Q000503:physiopathology; D055370:Lung Injury; D008353:Mannitol / Q000378:metabolism; D010100:Oxygen / Q000378:metabolism*; D011654:Pulmonary Edema / Q000628:therapy; D051381:Rats; D020133:Reverse Transcriptase Polymerase Chain Reaction; D000254:Sodium-Potassium-Exchanging ATPase / Q000737:chemistry* / Q000235:genetics*; D013482:Superoxide Dismutase / Q000378:metabolism; D013501:Surface-Active Agents / Q000494:pharmacology; D013997:Time Factors
D000975:Antioxidants; D018076:DNA, Complementary; D004234:Diuretics, Osmotic; D013501:Surface-Active Agents; D008353:Mannitol; D013482:Superoxide Dismutase; D000254:Sodium-Potassium-Exchanging ATPase; D005978:Glutathione; D010100:Oxygen